News About: Goverment
NHI Reimbursement Price to be set in Early December
The Health Insurance Policy Review Council (HIPRC) announced that the National Health Insurance (NHI) reimbursement and insurance prices are to be finally set upon completing the upcoming meetings scheduled on Decembe...
Drug Review Results Openly Disclosed by KFDA
A recent announcement by the KFDA indicates that it will openly communicate the completed drug review results generated from the approval procedures via its online website, www.kfda.go.kr.
The areas of disclosure...
Scope of drug public advertising to be trimmed.
The scope of drug public advertising ban seems to define to the prescription drugs and raw materials instead of the former ban on the therapeutic groups.
The new provision permits a public advertising for the dru...
KFDA to form a task force for small package of drugs.
The KFDA intends to discuss detailed plans in coming Dec. after the establishment of "Task Force" (TF) jointly with KPMA and KPA, to impose an obligation for the drug industry to make a small package drug. The TF will...
20 modified new drugs to come out by 2010.
The MOHW elected 50 key subjects in the pharmaceutical, medical equipment, cosmetic and food industries that might create a high value added in the 21th century and determined them intensively to foster as a core driv...
Monthly clinic and pharmacy NHI reimbursement respectively at 20,920 KW and 7,620KW.
The average monthly NHI reimbursement revenue showed a big difference between the private clinic and the pharmacy by 12 million or more.
The Health Insurance Review Agency reported that the monthly average dispensi...
Insurance benefits to be expanded to triple test
The Ministry of Health and Welfare announced that the current health insurance allowance will be expanded to the triple test from this December 1st as part of efforts to help married women.
The triple test refers t...
KFDA mulls manufacturing ban of general foods as tablets or capsules
The Korea Food and Drug Administration announced on November 19 its revised plan to ban the manufacturing/processing of all general foods (excluding health foods) in the forms of tablet or capsule, as part of efforts ...
KFDA approved Yuyu new anti-osteoporosis drug, Maxmavil
Yuyu announced to get the KFDA approval for Maxmavil, a new combined anti-osteoporosis drug formulated with Alrendronate and Calcitriol on Nov. 16 and therefore to launched its sales around coming March next year.
...
NHI reimbursement price to increase 2% next year
The NHI reimbursement price seems to be 2% up from this year by the Health Insurance Policy Council (HIPC) as a result of the negotiation failure between the National Health Insurance Corporation (NHIC) and th...
